AMO PHARMA
The company intends to use the funds to advance two clinical-stage pipeline assets targeting rare muscular and central nervous system disorders and to expand the AMO Pharma pipeline through acquisition of additional development-stage products.
AMO PHARMA
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-01-01
Address:
Wonersh, Surrey, United Kingdom
Country:
United Kingdom
Website Url:
http://www.amo-pharma.com
Total Employee:
1+
Status:
Active
Contact:
+4401483319070
Email Addresses:
[email protected]
Total Funding:
25 M USD
Technology used in webpage:
Google Maps Google Maps API Google Maps For Work British Server Location
Similar Organizations
Acasti Pharma
Acasti Pharma is an emerging biopharmaceutical company.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Woodford Investment Management
Woodford Investment Management investment in Private Equity Round - AMO Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-14 | Julia Jones Joins AMO Pharma As Chief Financial Officer And Board Member |
Official Site Inspections
http://www.amo-pharma.com Semrush global rank: 15.75 M Semrush visits lastest month: 1
- Host name: cp4.names.co.uk
- IP address: 85.233.160.141
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "AMO Pharma"
AMO Pharma
London UK Office AMO Pharma, Ltd. 1 Park Row Leeds LS1 5AB UK Phone: Tel: +44 (0) 1483 319070 Email: [email protected] North Carolina US Office 321 East Chapel Hill Street 3rd Floor Durham, NC 27701 Phone: 919-383 …See details»
AMO Pharma - Crunchbase Company Profile & Funding
AMO-02: AMO-02 (tideglusib) is in development for the treatment of congenital myotonic dystrophy and has potential for use in additional CNS, neuromuscular and other orphan …See details»
AMO Pharma Company Profile 2024: Valuation, …
AMO Pharma General Information Description. Operator of a privately held biopharmaceutical company intended to develop new treatments for serious and debilitating diseases including rare genetic disorders.See details»
AMO Pharma - Overview, News & Similar companies
Feb 14, 2024 Who is AMO Pharma. AMO Pharma is a biopharmaceutical company working to identify and advance promising therapies for the treatment of serious and debilitating disease …See details»
AMO Pharma Company Profile - Office Locations, Competitors
AMO Pharma is a biopharmaceutical company. The company aims to identify and advance therapies for the treatment of serious and debilitating diseases, including rare childhood-onset …See details»
AMO Pharma - Contacts, Employees, Board Members, Advisors
AMO Pharma has 5 current employee profiles, including CEO & Co - Founder Ibraheem Mahmood. AMO Pharma has 1 board member or advisor, Julia Jones. Contacts. Edit Contacts …See details»
AMO Pharma Completes Meeting with U.S. FDA and Outlines …
May 2, 2024 AMO Pharma Limited ("AMO Pharma"), a privately held clinical-stage specialty biopharmaceutical company focusing on rare genetic disorders with limited or no treatment …See details»
About - AMO-pharma.com
London UK Office AMO Pharma, Ltd., 1 Park Row, Leeds LS1 5AB UK Phone: Tel: +44 (0) 1483 319070 Email: [email protected] North Carolina US Office 321 East Chapel Hill Street 3rd Floor Durham, NC 27701 Phone: 919 …See details»
New medicines. Better lives. - AMO Pharma
AMO Pharma, Ltd. 321 East Chapel Hill Street 3rd Floor Durham, NC 27701 USA London UK Office: AMO Pharma, Ltd. 1 Park Row Leeds LS1 5AB UK Tel: +44 (0) 1483 319070 For more …See details»
AMO Pharma Announces Affirming Data from REACH-CDM …
AMO Pharma Limited ("AMO Pharma"), a privately held clinical-stage specialty biopharmaceutical company focusing on rare childhood-onset neurogenetic disorders with limited or no treatment …See details»
AMO Pharma Announces Collaboration with Population Health …
Feb 15, 2024 AMO Pharma Limited ("AMO Pharma"), a privately held clinical-stage specialty biopharmaceutical company focusing on rare genetic disorders with limited or no treatment …See details»
AMO Pharma - Meet the DM Drug Developers - Myotonic
In August 2020, AMO Pharma published the results of a Phase 2 study utilizing AMO-02 (Tideglusib) for Childhood Onset DM1 in Pediatric Neurology. AMO Pharma is excited to …See details»
AMO Pharma Announces MHRA Confirmation of CDM1-RS as
AMO-02 has a dual mechanism disrupting the pathogenic RNA repeat in CDM1 and inhibiting excess levels of the kinase GSK3β. About AMO Pharma AMO Pharma is a biopharmaceutical …See details»
Meet the DM Drug Developers: AMO Pharma - myotonic.org
In August 2020, AMO Pharma published the results of a Phase 2 study utilizing AMO-02 (Tideglusib) for Childhood Onset DM1 in Pediatric Neurology. We are excited to announce …See details»
News - AMO-pharma.com
Contact Us London UK Office AMO Pharma, Ltd., 1 Park Row, Leeds LS1 5AB UK Phone: Tel: +44 (0) 1483 319070 Email: [email protected] North Carolina US Office 321 East …See details»
AMO PHARMA LIMITED: FDA Grants Rare Pediatric Disease …
Nov 13, 2020 AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood onset neurogenetic disorders with limited or no treatment …See details»
AMO Pharma Announces Collaboration with Population Health …
Feb 15, 2024 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held clinical-stage specialty biopharmaceutical company focusing on rare genetic disorders with...See details»
AMO Pharma Announces Additional Private Equity Investment …
May 10, 2022 Current investors in AMO Pharma increase funding as Company passes two-thirds enrollment milestone in REACH-CDM pivotal clinical trial. LONDON, May 10, 2022 …See details»
News - AMO-pharma.com
London UK Office AMO Pharma, Ltd. 1 Park Row Leeds LS1 5AB UK Phone: Tel: +44 (0) 1483 319070 Email: [email protected] North Carolina US Office 321 East Chapel Hill Street …See details»